Pediatric Neurology
Volume 42, Issue 6 , Pages 385-393 , June 2010

Vitamin D and Bone Health Among Children With Epilepsy

  • Renée A. Shellhaas, MD, MS

      Affiliations

    • Corresponding Author InformationCommunications should be addressed to: Dr. Shellhaas; L3215 Women's Hospital; 1500 East Medical Center Drive; Ann Arbor, MI 48109-5203.
    • ,
  • Sucheta M. Joshi, MD, MS

Received 2 July 2009 ,Accepted 8 December 2009.

References 

  1. Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357:266–281
  2. Offermann G, Pinto V, Kruse R. Antiepileptic drugs and vitamin D supplementation. Epilepsia. 1979;20:3–15
  3. Vestergaard P. Epilepsy, osteoporosis and fracture risk—A meta-analysis. Acta Neurol Scand. 2005;112:277–286
  4. Souverein PC, Webb DJ, Weil JG, Van Staa TP, Egberts ACG. Use of antiepileptic drugs and risk of fractures: Case-control study among patients with epilepsy. Neurology. 2006;66:1318–1324
  5. Sheth RD, Gidal BE, Hermann BP. Pathological fractures in epilepsy. Epilepsy Behav. 2006;9:601–605
  6. Misra M, Pacaud D, Petryk A, Collett-Solberg PF, Kappy M Drug and Therapeutics Committee of the Lawson Wilkins Pediatric Endocrine Society. Vitamin D deficiency in children and its management: Review of current knowledge and recommendations. Pediatrics. 2008;122:398–417
  7. Rovner AJ, O'Brien KO. Hypovitaminosis D among healthy children in the United States: A review of the current evidence. Arch Pediatr Adolesc Med. 2008;162:513–519
  8. Holick MF. Vitamin D status: Measurement, interpretation, and clinical application. Ann Epidemiol. 2009;19:73–78
  9. Saintonge S, Band H, Gerber LM. Implications of a new definition of vitamin D deficiency in a multiracial US adolescent population: The National Health and Nutrition Examination Survey III. Pediatrics. 2009;123:797–803
  10. Yetley EA. Assessing the vitamin D status of the US population. Am J Clin Nutr. 2008;88(Suppl):S558–S564
  11. Wagner CL, Greer FR. Section on Breastfeeding and Committee on Nutrition. Prevention of rickets and vitamin D deficiency in infants, children, and adolescents. Pediatrics. 2008;122:1142–1152
  12. Volpe SL, Schall JI, Gallagher PR, Stallings VA, Bergqvist AGC. Nutrient intake of children with intractable epilepsy compared with healthy children. J Am Diet Assoc. 2007;107:1014–1018
  13. Verrotti A, Greco R, Latini G, Morgese G, Chiarelli F. Increased bone turnover in prepubertal, pubertal, and postpubertal patients receiving carbamazepine. Epilepsia. 2002;43:1488–1492
  14. Thomas MK, Lloyd-Jones DM, Thadhani RI, et al. Hypovitaminosis D in medical inpatients. N Engl J Med. 1998;338:777–783
  15. Baer MT, Kozlowski BW, Blyler EM, Trahms CM, Taylor ML, Hogan MP. Vitamin D, calcium, and bone status in children with developmental delay in relation to anticonvulsant use and ambulatory status. Am J Clin Nutr. 1997;65:1042–1051
  16. Bergqvist AGC, Schall JI, Stallings VA. Vitamin D status in children with intractable epilepsy, and impact of the ketogenic diet. Epilepsia. 2007;48:66–71
  17. Nettekoven S, Strohle A, Trunz B, et al. Effects of antiepileptic drug therapy on vitamin D status and biochemical markers of bone turnover in children with epilepsy. Eur J Pediatr. 2008;167:1369–1377
  18. El-Hajj Fuleihan G, Dib L, Yamout B, Sawaya R, Mikati MA. Predictors of bone density in ambulatory patients on antiepileptic drugs. Bone. 2008;43:149–155
  19. Mikati MA, Dib B, Yamout B, Sawaya R, Rahi AC, el-Hajj Fuleihan G. Two randomized vitamin D trials in ambulatory patients on anticonvulsants: Impact on bone. Neurology. 2006;67:2005–2014
  20. Tekgul H, Dizdarer G, Demir N, Ozturk C, Tutuncuoglu S. Antiepileptic drug-induced osteopenia in ambulatory epileptic children receiving a standard vitamin D3 supplement. J Pediatr Endocrinol Metab. 2005;18:585–588
  21. Tsukahara H, Kimura K, Todoroki Y, et al. Bone mineral status in ambulatory pediatric patients on long-term anti-epileptic drug therapy. Pediatr Int. 2002;44:247–253
  22. Bergqvist AGC, Schall JI, Stallings VA, Zemel BS. Progressive bone mineral content loss in children with intractable epilepsy treated with the ketogenic diet. Am J Clin Nutr. 2008;88:1678–1684
  23. Chung S, Ahn C. Effects of anti-epileptic drug therapy on bone mineral density in ambulatory epileptic children. Brain Dev. 1994;16:382–385
  24. Sheth RD, Binkley N, Hermann BP. Progressive bone deficit in epilepsy. Neurology. 2008;70:170–176
  25. Sheth RD, Hermann BP. Bone in idiopathic and symptomatic epilepsy. Epilepsy Res. 2008;78:71–76
  26. Sheth RD, Wesolowski CA, Jacob JC, et al. Effect of carbamazepine and valproate on bone mineral density. J Pediatr. 1995;127:256–262
  27. Tekgul H, Serdaroglu A, Huseyinov A, Gokben S. Bone mineral status in pediatric outpatients on antiepileptic drug monotherapy. J Child Neurol. 2006;21:411–414
  28. Akin R, Okutan V, Sarici U, Altunbas A, Gokcay E. Evaluation of bone mineral density in children receiving antiepileptic drugs. Pediatr Neurol. 1998;19:129–131
  29. Altay EE, Serdaroglu A, Tumer L, Gucuyener K, Hasanoglu A. Evaluation of bone mineral metabolism in children receiving carbamazepine and valproic acid. J Pediatr Endocrinol Metab. 2000;13:933–939
  30. Kafali G, Erselcan T, Tanzer F. Effect of antiepileptic drugs on bone mineral density in children between ages 6 and 12 years. Clin Pediatr (Phila). 1999;38:93–98
  31. Babayigit A, Dirik E, Bober E, Cakmakci H. Adverse effects of antiepileptic drugs on bone mineral density. Pediatr Neurol. 2006;35:177–181
  32. Chou I-J, Lin K-L, Wang H-S, Wang C-J. Evaluation of bone mineral density in children receiving carbamazepine or valproate monotherapy. Acta Paediatr Taiwan. 2007;48:317–322
  33. Cansu A, Ediz Y, Ayse S, et al. Evaluation of bone turnover in epileptic children using oxcarbazepine. Pediatr Neurol. 2008;39:266–271
  34. Nicolaidou P, Georgouli H, Kotsalis H, et al. Effects of anticonvulsant therapy on vitamin D status in children: Prospective monitoring study. J Child Neurol. 2006;21:205–209
  35. Guo C-Y, Ronene GM, Atkinson SA. Long-term valproate and lamotrigine treatment may be a marker for reduced growth and bone mass in children with epilepsy. Epilepsia. 2001;42:1141–1147
  36. French JA, Kanner AM, Bautista J, et al. Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new onset epilepsy. Neurology. 2004;62:1252–1260
  37. Mintzer S, Boppana P, Toguri J, DeSantis A. Vitamin D levels and bone turnover in epilepsy patients taking carbamazepine or oxcarbazepine. Epilepsia. 2006;47:510–515
  38. Valmadrid C, Voorhees C, Litt B, Schneyer CR. Practice patterns of neurologists regarding bone and mineral effects of antiepileptic drug therapy. Arch Neurol. 2001;58:1369–1374

PII: S0887-8994(09)00586-4

doi: 10.1016/j.pediatrneurol.2009.12.005

Pediatric Neurology
Volume 42, Issue 6 , Pages 385-393 , June 2010

Article Tools